Responses
Regular and young investigator award abstracts
Checkpoint blockade therapy
200 NBTXR3 nanoparticle with immunoradiation improves survival and generates long-term anti-tumor memory in an anti-PD1 resistant murine lung cancer model
Compose a Response to This Article
Other responses
No responses have been published for this article.
